ATRC

AtriCure, Inc. Common Stock

$57.30

Current Price

All

AI analysis

Read what the AI thinks of AtriCure, Inc. Common Stock in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

$0.22

P/E

261.4

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

After the close · Expected EPS: -$0.05

Nov 4

Posts

No posts about ATRC yet.

About AtriCure, Inc. Common Stock

AtriCure makes medical devices that surgeons use to treat atrial fibrillation, a common irregular heartbeat, and to manage a heart area linked to stroke risk. Hospitals buy its tools, so revenue comes from selling devices for each procedure. The company is based in the US and trades as a mid-sized healthcare company.